These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 52903)

  • 21. Immunologic studies on platelet antiproteases.
    Nalli G; Majolino I; Fornasari PM; Cattaneo G; Malamani GD; Almasio P; Piovella F; Ascari E
    Haematologica; 1978 Apr; 63(2):156-62. PubMed ID: 79518
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the ontogeny and significance in neonatal disease of the fibrinolysin system and of fibrin stabilizing factor.
    Ambrus CM; Weintraub D; Niswander K; Ambrus JL
    Thromb Diath Haemorrh; 1968 Jul; 19(3):599-600. PubMed ID: 4236829
    [No Abstract]   [Full Text] [Related]  

  • 23. Alpha-2-macroglobulin levels in early respiratory distress syndrome.
    Yurdakök M; Yiğit S; Gürakan B; Dündar S; Kirazli S
    Turk J Pediatr; 1998; 40(4):567-70. PubMed ID: 10028866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of smoking on the haemostatic mechanism in pregnancy.
    Condie RG; Pirani BB
    Acta Obstet Gynecol Scand; 1977; 56(1):5-8. PubMed ID: 65896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effector mechanisms and products of the physiological fibrinolytic systems.
    Edgington TS; Plow EF
    Prog Clin Biol Res; 1976; 5():85-120. PubMed ID: 61595
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: The contribution of individual protease inhibitors to plasma antiplasmin activity.
    Crawford GP; Ogston D; Douglas AS
    Thromb Diath Haemorrh; 1975 Sep; 34(1):319. PubMed ID: 52898
    [No Abstract]   [Full Text] [Related]  

  • 27. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional fibrinolytic study in coronary artery disease.
    Patrassi GM; Bisetti P; Chioin R; Procidano M; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):307-12. PubMed ID: 6179833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fibrinogenderivatives in plasma and serum of newborn infants with respiratory distress syndrome].
    Lenk H; Weissbach G; Braun W; Domula M; Vogtmann C
    Acta Paediatr Acad Sci Hung; 1976; 17(2):135-46. PubMed ID: 1032734
    [No Abstract]   [Full Text] [Related]  

  • 30. The measurement of human plasma antiplasmin activity by radial diffusion assay.
    Andes WA
    Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of hyperbaric oxygen in asphyxia neonatorum and the respiratory distress syndrome.
    Hutchison JH; Kerr MM
    Acta Anaesthesiol Scand Suppl; 1966; 25():397-8. PubMed ID: 6003308
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals.
    Ambrus JL; Ambrus CM
    J Med; 1990; 21(1-2):67-84. PubMed ID: 2145377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biological changes during the local administration of small doses of urokinase].
    Michaud A; Aiach M; Fiessinger JN; Vayssairat M; Juillet Y
    Nouv Presse Med; 1978 Oct; 7(35):3151. PubMed ID: 152910
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: The relationship between antithrombin III, progressive antithrombin activity and anti Xa activity in plasma.
    Whigham K; Howie PW; Forbes CD; Prentice CR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):365. PubMed ID: 52904
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I; Lee JH; Kutschera E; Winkler UH; Kuhl H
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
    Schwarz HP; Aiginger P; Kuzmits R
    Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coagulation studies from capillary blood in newborn infants].
    Muntean W; Müller WD
    Helv Paediatr Acta; 1976 Aug; 31(2):149-58. PubMed ID: 955938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
    Matsuda T
    Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
    [No Abstract]   [Full Text] [Related]  

  • 40. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.